Clinical Medicine Insights-Endocrinology and Diabetes最新文献

{"title":"Efficacy of Transdermal Dihydrotestosterone and Testosterone Enanthate for Penile Augmentation in Patients With Idiopathic Micropenis: A Comparative Randomized Study.","authors":"Marouan Karrou,&nbsp;Najoua Messaoudi,&nbsp;Imane Assarrar,&nbsp;Achwak Alla,&nbsp;Siham Rouf,&nbsp;Hanane Latrech","doi":"10.1177/11795514231208328","DOIUrl":"10.1177/11795514231208328","url":null,"abstract":"<p><strong>Objectives: </strong>Our study aimed to compare the efficacy of transdermal dihydrotestosterone and testosterone enanthate in treating idiopathic micropenis.</p><p><strong>Patients and methods: </strong>It's a comparative randomized study of 49 patients with idiopathic micropenis who are followed up in the Endocrinology-Diabetology and Nutrition Department of Mohammed VI University Hospital Center of Oujda, Morocco. The study was conducted from December 2019 to April 2021. All patients received a clinical examination including measurement of penis size before and after hormonal treatment. The patients were divided into two random groups, each group received a different drug, the first arm was treated with transdermal dihydrotestosterone (27 patients) and the second arm was treated with testosterone enanthate (22 patients). The Trial registration number was researchregistry7745.</p><p><strong>Results: </strong>The majority of the patients were children. The mean age was 9.7 ± 4.4 years. In the first arm, the mean penile size increased from -2.42 SD to -0.7 SD with a gain of 2.37 cm on average. In the second arm, the mean size increased from -2.48 SD to -0.69 SD, with a gain of 1.82 cm on average. The increase in penile size in the first arm was significantly greater than in the second arm (<i>P</i> = .008). No side effects were detected in both arms.</p><p><strong>Discussion and conclusion: </strong>In the present study, we demonstrated the superiority of transdermal DHT compared to injectable exogenous testosterone in the treatment of idiopathic micropenis. According to the age subgroups, there was no significant difference between the 2 treatments in each age group.</p>","PeriodicalId":44715,"journal":{"name":"Clinical Medicine Insights-Endocrinology and Diabetes","volume":"16 ","pages":"11795514231208328"},"PeriodicalIF":2.8,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619192/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71427729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Incidence of Urgent Tube Shunt Surgery for Diabetic Neovascular Glaucoma at a Tertiary Academic Medical Center.","authors":"Megan Corinne LaRocca,&nbsp;Andrew K Smith,&nbsp;Don S Minckler,&nbsp;Ken Y Lin","doi":"10.1177/11795514231203865","DOIUrl":"https://doi.org/10.1177/11795514231203865","url":null,"abstract":"<p><strong>Background: </strong>Diabetic neovascular glaucoma is a secondary glaucoma that may require immediate correction of elevated intraocular pressure to control pain and protect the optic nerve. While there is a seasonal trend to glucose levels, it is unknown if a seasonal trend exists for diabetic neovascular glaucoma.</p><p><strong>Objective: </strong>This study evaluates the incidence of urgent glaucoma tube shunt implantation in diabetic neovascular glaucoma in a tertiary academic referral center in Southern California.</p><p><strong>Methods: </strong>Electronic medical records were queried for urgent glaucoma tube shunt surgery from 2014 to 2021. The number of cases were separated by month of occurrence, and average hemoglobin A1c values were calculated per month. Data were analyzed via ANOVA tests and one-tailed t-tests.</p><p><strong>Results: </strong>A total of 127 cases were identified. The months of March and April contained the most cases averaging 3 and 2.75 cases, respectively. April had statistically significant higher case numbers than that of other months (<i>P</i> = .041). ANOVA tests excluding April showed no statistically significant difference between the remaining months (<i>P</i> = .901). Average hemoglobin A1c values were highest in the months of April and March at 9.8 and 9.6%, respectively.</p><p><strong>Conclusion: </strong>Emergency glaucoma tube shunt surgery for diabetic neovascular glaucoma occurs most frequently in April. This observation may provide insight into disease prevention through diabetes management and help improve surgical operations such that staffing and resources are allocated accordingly.</p>","PeriodicalId":44715,"journal":{"name":"Clinical Medicine Insights-Endocrinology and Diabetes","volume":"16 ","pages":"11795514231203865"},"PeriodicalIF":2.8,"publicationDate":"2023-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612438/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71414652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Therapeutic Effect of <i>Tinospora cordifolia (Willd)</i> Extracts on Letrozole-Induced Polycystic Ovarian Syndrome and its Complications in Murine Model.","authors":"Ritu Rani, Avinash Kumar Sharma, Havagiray R Chitme","doi":"10.1177/11795514231203864","DOIUrl":"10.1177/11795514231203864","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Tinosopora cordifolia (&lt;i&gt;Willd)&lt;/i&gt; (TC) is commonly used in Ayurvedic medicine since long time for number of ailments and its preparations are also considered by food safety and standards authority of India as nutritional supplement. However the scientific evidence on its possible safety and efficacy in polycystic ovarian syndrome and associated complications was not studied in detail.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;The purpose of this investigation is to examine whether or not &lt;i&gt;TC&lt;/i&gt; can have therapeutic effects on letrozole induced PCOS and related complications such as body weight, dyslipidaemia, glucose tolerance, hormonal regulation, insulin resistance and sensitivity, severity of PCOS and histopathological changes in ovary using mice animal model.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design: &lt;/strong&gt;Present study is a preclinical study involving laboratory animals.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods and analysis: &lt;/strong&gt;After verifying the absence of PCOS, the animals began receiving Letrozole, which lasted for 21 days. Fasting blood glucose (FBG), the oral glucose tolerance test (OGTT), triglycerides, cholesterol, and weight were recorded. The levels of hormones like oestrogen, progesterone, insulin, testosterone, luteinising hormone (LH) and follicle stimulating hormone (FSH), histopathology was carried out.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Ethics: &lt;/strong&gt;The Institutional Animal Ethics Committee at DITU gave its clearance to the animal experimentation on July 10, 2021 (DITU/IAEC/21-22/07-06).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Discussion: &lt;/strong&gt;The majority of cornified epithelial cells were seen in groups treated with &lt;i&gt;TC&lt;/i&gt; extract during the estrous phase of the cycle. Mice exposed to &lt;i&gt;TC&lt;/i&gt; retained normal body weight. FBG, 1- and 2-hour OGTT, triglyceride and cholesterol levels were all significantly improved by extracts. Estradiol, progesterone, testosterone, insulin, LH and FSH concentration were all corrected in &lt;i&gt;TC&lt;/i&gt;-treated animals. The HOMA-IR, HOMA-Beta and QUICKI values were also corrected with &lt;i&gt;TC&lt;/i&gt; extracts. The morphological and microscopic features of the ovary were also greatly enhanced. Based on these findings, we conclude that treating PCOS mice with &lt;i&gt;TC&lt;/i&gt; extracts significantly ameliorates the disease and severity down to nil-to-moderate levels by reducing hyperinsulinemia, hyperandrogenism, dyslipidaemia, enhancing insulin sensitivity, correcting oestrogen, progesterone, LH and FSH levels via enhanced ovarian function. Further molecular and cellular level of study is recommended for further elaboration of mechanism of action.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Plain language summaries: &lt;/strong&gt;• &lt;i&gt;Tinospora cordifolia&lt;/i&gt; satva, oil and hydroalcoholic extract were studied in letrozole-induced PCOS in mice model• Anti PCOS efficacy of 3 preparations studied with respect to their mechanism of action in detail• For the first time proposing method of calculating severity of PCOS in animal model• &lt;i&gt;Tinospora cordifolia&lt;/i&gt; oil preparation complete","PeriodicalId":44715,"journal":{"name":"Clinical Medicine Insights-Endocrinology and Diabetes","volume":"16 ","pages":"11795514231203864"},"PeriodicalIF":2.7,"publicationDate":"2023-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612436/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71414653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Insulin Resistance in Adolescents and Youth With Type 1 Diabetes: A Review of Problems and Solutions.","authors":"Anuradha Khadilkar,&nbsp;Chirantap Oza,&nbsp;Shruti A Mondkar","doi":"10.1177/11795514231206730","DOIUrl":"https://doi.org/10.1177/11795514231206730","url":null,"abstract":"<p><p>Though insulin resistance (IR) was previously considered a feature of only type 2 Diabetes (T2DM), its development in type 1 Diabetes (T1DM) is not an uncommon occurrence, the causes of which are multifactorial (gender, pubertal status, diabetes duration, ethnicity, genetics, adiposity, glycemic control, chronic inflammation). Despite improvements in glucose, blood pressure and lipid profile, vascular complications (coronary artery disease and nephropathy) continue to remain common causes of morbidity and mortality in T1DM. Aggressive glycemic control reduces but does not eliminate the risk of IR. IR accelerates the development of micro and macrovascular complications, many of which can be potentially reversed if diagnosed and managed early. Lack of endogenous insulin production makes estimation of insulin sensitivity in T1DM difficult. As hyperinsulinemic-euglycemic clamp studies are cumbersome and invasive, the use of prediction equations for calculating estimated insulin sensitivity may prove to be useful. Along with intensive insulin therapy, dietary modifications and increasing physical activity, the role of Metformin in managing IR in T1DM is becoming increasingly popular. Metformin adjunct therapy in T1DM has been shown to improve insulin sensitivity, glycemic control, lipid profile, body composition, vascular smooth muscle function, thereby reducing the risk of vascular complications, as well as reversal of early vascular dysfunction. However, further studies to assess long-term efficacy and safety of Metformin use in adolescents and youth with T1DM are needed. This review aims at revisiting the pathophysiology of IR in T1DM and techniques of identifying those at risk so as to put into action various strategies for management of the same.</p>","PeriodicalId":44715,"journal":{"name":"Clinical Medicine Insights-Endocrinology and Diabetes","volume":"16 ","pages":"11795514231206730"},"PeriodicalIF":2.8,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604500/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71414651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Lessons Learned From COVID-19 Lockdown: An ASPED/MENA Study on Lifestyle Changes and Quality of Life During Ramadan Fasting in Children and Adolescents Living With Type 1 Diabetes.","authors":"Amir Babiker,&nbsp;Nancy Samir Elbarbary,&nbsp;Bothainah Alaqeel,&nbsp;Khalid Al Noaim,&nbsp;Saif Al Yaarubi,&nbsp;Dalia Al-Abdulrazzaq,&nbsp;Hessa Al-Kandari,&nbsp;Haya Alkhayyat,&nbsp;Rasha Odeh,&nbsp;Omer Babiker,&nbsp;Abdulsalam Abu-Libdeh,&nbsp;Amal Aljohani,&nbsp;Noof Al Abdul Salam,&nbsp;Fatima Al-Juailla,&nbsp;Emad Masuadi,&nbsp;Asma Deeb,&nbsp;Jill Weissberg-Benchell,&nbsp;Alice M Gregory,&nbsp;Mohamed Hassanein,&nbsp;Ibrahim Al Alwan","doi":"10.1177/11795514231203907","DOIUrl":"10.1177/11795514231203907","url":null,"abstract":"<p><strong>Background: </strong>Lockdown was a unique experience that affected many aspects of life, particularly during the challenge of Ramadan fasting (RF). Studying this can increase understanding of the effects of lifestyle changes on quality of life (QoL) for children with type 1 diabetes (T1D) during RF.</p><p><strong>Methods: </strong>A cross-sectional study that assessed the effect of lockdown on lifestyle and QoL on fasting children living with T1D during Ramadan in the Middle East and North Africa region (2020-2021). We compared the child (self) and parent (proxy) reports using PEDQoL v3.0 disease specific questionnaire during lockdown and non-lockdown periods, and assessed correlations with lifestyle changes using regression and gap analyses.</p><p><strong>Results: </strong>A total of 998 reports from 499 children with T1D aged 8 to 18 years (study = 276, control = 223), and their parents during RF in lockdown and non-lockdown periods. Fathers were more involved in their children's care during lockdown (<i>P</i> = .019). Patients had better compliance with treatment (<i>P</i> = .002), a reversed sleep pattern (<i>P</i> = .033), increased food intake (<i>P</i> ⩽ .001), and less exercise (<i>P</i> < .001). Children and parents perceived better QoL during lockdown (<i>P</i> ⩽.001) with no differences between their reports in \"Diabetes Symptoms\", \"Treatment Adherence,\" and \"Communication\" domains. Self and proxy reports were different in all domains during non-lockdown (<i>P</i> = <.001-.009). In gap analysis, although not statistically significant, the gap was approximated between children's and parents' perceptions in all domains during lockdown.</p><p><strong>Conclusion: </strong>COVID-19 lockdown had a positive impact on QoL of children living with T1D during RF, possibly due to lifestyle changes and superior psychosocial family dynamics.</p>","PeriodicalId":44715,"journal":{"name":"Clinical Medicine Insights-Endocrinology and Diabetes","volume":"16 ","pages":"11795514231203907"},"PeriodicalIF":2.8,"publicationDate":"2023-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/72/a0/10.1177_11795514231203907.PMC10588419.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49692982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of Body Composition Variables between Post-Bariatric Surgery Patients and Non-Operative Controls.","authors":"Sirinrat Tangjittrong,&nbsp;Suthep Udomsawaengsup,&nbsp;Patchaya Boonchaya-Anant","doi":"10.1177/11795514231206731","DOIUrl":"https://doi.org/10.1177/11795514231206731","url":null,"abstract":"<p><strong>Background: </strong>Since bariatric surgery results in massive weight loss, it may be associated with a disproportionate decrease in lean body mass.</p><p><strong>Objective: </strong>To evaluate body composition in post-bariatric surgery patients who had a successful weight loss at 12 months (>50% excess weight loss) with comparisons to healthy controls who were matched for age, sex and BMI.</p><p><strong>Methods: </strong>This is an observational analytic study using data from post-bariatric surgery patients who had laparoscopic Roux-en-Y gastric bypass (RYGB) or laparoscopic sleeve gastrectomy (SG) at King Chulalongkorn Memorial Hospital. Patients who had percentage excessive weight loss (%EWL) >50% and achieved a BMI of <30 kg/m² within 12 months after the surgery were included. Non-operative healthy controls matched for sex, age, and BMI (1:1) were recruited. The 12-month post-bariatric surgery BMI was used to match the BMI of the control subjects. A single bioelectrical impedance analysis (BIA) (Inbody 770) machine was used for the entire study.</p><p><strong>Results: </strong>Sixty participants were included in this study. There are 30 post-bariatric surgery patients (female n = 19, male n = 11) and 30 non-operative controls (female n = 19, male n = 11). The 12-month post-bariatric surgery patients had lower percentage of body fat (PBF) (30.6% vs 35.9%, <i>P</i>-value .001) and trunk fat mass (10.3 vs 12.4 kg, <i>P</i>-value .04) than non-operative controls. The 12-month post-bariatric surgery patients also were found to have more soft lean mass (SLM) (47.7 vs 39.9 kg, <i>P</i>-value .001), fat free mass (FFM) (51.1 vs 42.3 kg, <i>P</i>-value .001), skeletal muscle mass (SMM) (27.5 vs 23 kg, <i>P</i>-value .003), and trunk lean mass (21.2 vs 19 kg, <i>P</i>-value .02).</p><p><strong>Conclusion: </strong>Despite the significant reductions in all body composition variables in post-bariatric surgery patients at 12-month follow-up, both fat free mass and skeletal muscle mass were found to be higher in the surgical patients compared to the control group.</p><p><strong>Clinical trials: </strong>Thai Clinical Trials Registry, https://thaiclinicaltrials.org/ID:TCTR20200223003.</p>","PeriodicalId":44715,"journal":{"name":"Clinical Medicine Insights-Endocrinology and Diabetes","volume":"16 ","pages":"11795514231206731"},"PeriodicalIF":2.8,"publicationDate":"2023-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f3/22/10.1177_11795514231206731.PMC10583510.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49683359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Insights Into Metformin XR Pharmacotherapy Knowledge Among Community Pharmacists: A Cross-Sectional Study.","authors":"Ammar Abdulrahman Jairoun,&nbsp;Sabaa Saleh Al-Hemyari,&nbsp;Moyad Shahwan,&nbsp;Nageeb Hassan,&nbsp;Sa'ed H Zyoud,&nbsp;Ammar Ali Saleh Jaber,&nbsp;Tariq Al-Qirim","doi":"10.1177/11795514231203913","DOIUrl":"10.1177/11795514231203913","url":null,"abstract":"<p><strong>Background: </strong>There is a little knowledge on the extent to which healthcare providers understand and accept the professional recommendations and appropriate dosing strategy regarding metformin XR.</p><p><strong>Objectives: </strong>To evaluate UAE community pharmacists' knowledge, attitude, and practices (KAP) concerning metformin XR.</p><p><strong>Methods: </strong>This is a cross-sectional research study conducted amongst licensed community pharmacists. The survey took place via a questionnaire and physical interviews were held. The survey used in this study included questions on demographics and questions on the participants' attitudes, knowledge and practices concerning metformin XR. The factors influencing KAP regarding metformin XR were examined via simple logistic regression analysis.</p><p><strong>Results: </strong>Threehundred fifty-three (n = 353) participants were recruited in the study. Independent pharmacies constituted 57.5% of this study sample and 42.5% were chain pharmacies. The average knowledge score about metformin XR tablets was 42.5% with a confidence interval (CI) of 95% [37.3%, 47.4]. Better knowledge scores on metformin XR tablets was observed in respondents aged ⩾40 years (OR 2.97, 95% CI 1.63-5.4), having greater than 10 years in terms of experience (OR 2.28; 95% CI 1.25-4.16) and pharmacist graduated from Regional or international universities (OR 2.08; 95% CI 1.34-3.24). About 78% (n = 275) of the participants believed that metformin XR tablets have better efficacy and 63.2% (n = 233) indicated that metformin IR was associated with greater adverse effects.</p><p><strong>Conclusion: </strong>This study demonstrated a distinct gap in knowledge, attitude and practice pertaining to metformin XR among community pharmacists in the UAE. The community pharmacists need to enhance their practice by receiving accurate and reliable data to support their decision-making on the prescribing of metformin XR. The implementation of novel guidelines and evidence dissemination strategies may help bridge this gap.</p>","PeriodicalId":44715,"journal":{"name":"Clinical Medicine Insights-Endocrinology and Diabetes","volume":"16 ","pages":"11795514231203913"},"PeriodicalIF":2.8,"publicationDate":"2023-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6e/90/10.1177_11795514231203913.PMC10576939.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Inactive Matrix Gla Protein in Relation to Renal and Cardiac Functions and Cardiac Valvular Calcification Among Type 2 Diabetes Patients.","authors":"Sara Reda,&nbsp;Olfat Fawzy,&nbsp;Doaa Sayed,&nbsp;Ghada Mohamed,&nbsp;Emad Gamil Khidr","doi":"10.1177/11795514231203862","DOIUrl":"10.1177/11795514231203862","url":null,"abstract":"<p><strong>Background: </strong>Matrix Gla protein (MGP) is a robust innate suppressor of the detrimental process of vascular calcification in the human body.</p><p><strong>Objectives: </strong>The interrelationship between circulating MGP levels and renal and cardiac dysfunction, besides echocardiographic calcification score (ECS) was investigated in a sample of type 2 diabetes (T2D) patients.</p><p><strong>Methods: </strong>The study included 130 subjects. They were 95 patients with T2D and 35 age- and sex-matched healthy controls. Patients were further subdivided into 52 T2D patients without DKD (eGFR ⩾ 60 ml/minute/1.73 m²) and 43 T2D persons with DKD (eGFR > 60 ml/minute/1.73 m²). Serum MGP levels, determined by ELISA, renal function tests, lipid profile, and echocardiography were studied in all participants.</p><p><strong>Results: </strong>Significantly elevated circulating inactive MGP level was noted in individuals having T2D compared to controls. It correlated negatively with eGFR and left ventricular (LV) diastolic and systolic functions and positively with indices of LV hypertrophy. ECS was significantly increased in both T2D groups compared to controls and in DKD group compared to the diabetic group without DKD. A significant positive correlation was observed between inactive MGP and ECS.</p><p><strong>Conclusion: </strong>Serum inactive MGP may contribute to the development of DKD and to the associated process of cardiac valvular calcification. It may be a beneficial diagnostic marker for early prediction of cardiac calcification and preclinical LV systolic and diastolic dysfunction in T2D patients, especially in those complicated with DKD.</p>","PeriodicalId":44715,"journal":{"name":"Clinical Medicine Insights-Endocrinology and Diabetes","volume":"16 ","pages":"11795514231203862"},"PeriodicalIF":2.8,"publicationDate":"2023-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/de/1e/10.1177_11795514231203862.PMC10576928.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"CHILDSTAR: CHIldren Living With Diabetes See and Thrive with AI Review.","authors":"Katie Curran,&nbsp;Noelle Whitestone,&nbsp;Bedowra Zabeen,&nbsp;Munir Ahmed,&nbsp;Lutful Husain,&nbsp;Mohammed Alauddin,&nbsp;Mohammad Awlad Hossain,&nbsp;Jennifer L Patnaik,&nbsp;Gabriella Lanoutee,&nbsp;David Hunter Cherwek,&nbsp;Nathan Congdon,&nbsp;Tunde Peto,&nbsp;Nicolas Jaccard","doi":"10.1177/11795514231203867","DOIUrl":"https://doi.org/10.1177/11795514231203867","url":null,"abstract":"<p><strong>Background: </strong>Artificial intelligence (AI) appears capable of detecting diabetic retinopathy (DR) with a high degree of accuracy in adults; however, there are few studies in children and young adults.</p><p><strong>Methods: </strong>Children and young adults (3-26 years) with type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM) were screened at the Dhaka BIRDEM-2 hospital, Bangladesh. All gradable fundus images were uploaded to Cybersight AI for interpretation. Two main outcomes were considered at a patient level: 1) Any DR, defined as mild non-proliferative diabetic retinopathy (NPDR or more severe; and 2) Referable DR, defined as moderate NPDR or more severe. Diagnostic test performance comparing Orbis International's Cybersight AI with the reference standard, a fully qualified optometrist certified in DR grading, was assessed using the Matthews correlation coefficient (MCC), area under the receiver operating characteristic curve (AUC-ROC), area under the precision-recall curve (AUC-PR), sensitivity, specificity, positive and negative predictive values.</p><p><strong>Results: </strong>Among 1274 participants (53.1% female, mean age 16.7 years), 19.4% (n = 247) had any DR according to AI. For referable DR, 2.35% (n = 30) were detected by AI. The sensitivity and specificity of AI for any DR were 75.5% (CI 69.7-81.3%) and 91.8% (CI 90.2-93.5%) respectively, and for referable DR, these values were 84.2% (CI 67.8-100%) and 98.9% (CI 98.3%-99.5%). The MCC, AUC-ROC and the AUC-PR for referable DR were 63.4, 91.2 and 76.2% respectively. AI was most successful in accurately classifying younger children with shorter duration of diabetes.</p><p><strong>Conclusions: </strong>Cybersight AI accurately detected any DR and referable DR among children and young adults, despite its algorithms having been trained on adults. The observed high specificity is particularly important to avoid over-referral in low-resource settings. AI may be an effective tool to reduce demands on scarce physician resources for the care of children with diabetes in low-resource settings.</p>","PeriodicalId":44715,"journal":{"name":"Clinical Medicine Insights-Endocrinology and Diabetes","volume":"16 ","pages":"11795514231203867"},"PeriodicalIF":2.8,"publicationDate":"2023-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563496/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41215473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Fast-Access Multidisciplinary Approach to Management of Diabetic Foot Ulcers: The Diabetic Rapid Evaluation and Lower Limb Amputation Management (DREAM) Clinic.","authors":"Fengjie Tang,&nbsp;Siti Nurfarahdillah Binte Abdul Razak,&nbsp;Jerilyn Xiling Tan,&nbsp;Edward Tieng Chek Choke,&nbsp;Sueziani Binte Zainudin","doi":"10.1177/11795514231196464","DOIUrl":"https://doi.org/10.1177/11795514231196464","url":null,"abstract":"<p><strong>Background: </strong>Diabetic foot ulcers (DFUs) are debilitating to the patient and costly for the healthcare system. We set up the Diabetic Rapid Evaluation and lower limb Amputation Management (DREAM) clinic with the aim of providing early directed specialist care to patients with DFUs. With early management, we hope to treat DFUs in its early stages, reducing the need for and associated morbidity of major and minor lower limb amputations.</p><p><strong>Objectives: </strong>We evaluated the outcomes of the fast-access DREAM clinic with multi-disciplinary evaluation for patients with DFUs. Outcomes include time from the point of referral to DREAM clinic evaluation, amputation rates and wound healing rates.</p><p><strong>Design: </strong>Patients presenting with DFU to the DREAM clinic were enrolled. A podiatrist made the first assessment, followed by immediate specialist consultation with Endocrinologists, Vascular surgeons or Orthopaedic surgeons as required.</p><p><strong>Methods: </strong>Data on baseline demographics and DFU characteristics were collected. Outcomes evaluated were wound healing at 12 weeks, wound salvage rates, time to DREAM clinic access and time to specialist referral.</p><p><strong>Results: </strong>Sixty-eight patients were enrolled, with 57.3% males, and mean age of 63 ± 13.0 years. Majority of ulcers were classified as neuropathic (41.3%) and located at the digits (40%). At 12-weeks follow-up, 1 had undergone major amputation, 9 minor amputations and 4 surgical debridements. The median time to DREAM clinic evaluation from first presentation was 3 days (IQR 7). Eleven (16.2%) required >1 specialist consult. Twenty (29.4%) were hospitalised for treatment. Twelve underwent revascularisation within 4 days (IQR 3.5). Twenty-four patients (35.3%) continued podiatry follow-up, having 28 DFUs in which 20 (71.4%) healed within 12 weeks.</p><p><strong>Conclusion: </strong>The fast-access multidisciplinary DREAM clinic shows promising outcomes with lower major amputation rates and exemplary DFU healing outcomes.</p>","PeriodicalId":44715,"journal":{"name":"Clinical Medicine Insights-Endocrinology and Diabetes","volume":"16 ","pages":"11795514231196464"},"PeriodicalIF":2.8,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7b/56/10.1177_11795514231196464.PMC10541744.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41153338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}